This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Drug Screening Market

Drug Screening Market Analysis by Product and Service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Consumables, and Drug Screening Service), Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Others), End User, & Region - Forecast to 2022 - 2032

Market Insights on Drug Screening covering sales outlook, demand forecast & up-to-date key trends

Drug Screening Market Outlook

[333 Pages Report] The global drug screening market is projected to expand at a 16% CAGR from US$ 5.3 Bn in 2021 to US$ 18 Bn by 2032 showing an immense improvement.

“Teenage illicit alcohol usage, rising road accidents owing to a drug overdose while driving, and prescription medication abuse are predicted to fuel market revenue growth."

The rise in regulatory approvals for the drug screening laboratory services market is ascribed to increased drug and alcohol usage and the implementation of rigorous legislation demanding alcohol and drug test. Bans on alcohol use in Islamic nations and limitations on an occupational drug test in select countries, on the other hand, may limit the market's growth to some extent.

Attributes

Details

Drug Screening Market CAGR (2022 – 2032)

16%

Drug Screening Market (2026)

US$ 11 Bn

Drug Screening Market Attraction

Imposition of strict laws about drug abuse to offer opportunities in North America.

What is the COVID-19 Impact on Drug Screening Market?

Covid-19 pandemic resulted in a worldwide restriction on the movement of people and led to the isolation of individuals in their own homes. This is the primary reason for the drop in demand for drug screening services as most of the workplaces were shut down, and healthcare resources were diverted to take care of covid-19 patients. Trade restrictions also had a similar negative impact on equipment availability for drug screening procedures.

But with the covid-19 situation getting controlled and commercial activities returning to customary conditions, the drug testing industry is predicted to revive gradually and speed up during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Drivers, Restraints, Opportunities, & Threats in the Drug Screening Market?

“The development of improved screening technology and growing awareness of the benefits of alcohol or drug screening are creating business opportunities.”

Drug misuse and alcohol usage are on the rise all around the world. According to the World Drug Report 2021, 275 million persons aged 15–64, or one out of every 18 people in that age group, took drugs at least once in the preceding year (range: 175 million to 374 million). 

Drug use problems were expected to affect 36.3 million individuals worldwide, accounting for over 13% of the global population. Drug use killed about half a million individuals in the same year, and drug use disorders resulted in the loss of 18 million years of a healthy life, primarily owing to opioids. 

Similar increases in alcohol intake have been seen, with the resultant rise in the prevalence of impaired driving. Development of drug screening products and services on the road, boosting the total market growth.

Which Drivers are Limiting the Drug Screening Adoption?

Alcohol and drug tests in the workplace are considered a breach of employee privacy in certain nations, including Canada, Colombia, Argentina, Chile, and South Africa. In France, for example, pre-employment saliva drug testing is only done when doctors prescribe it. 

Workplace alcohol and drug tests are illegal in Poland and the Czech Republic. In Canada, Eastern Canadian case laws allow alcohol and immunoassay drug tests only where occupational activities are fundamentally risky or when alcohol and drug testing is confined to a few specific circumstances. 

What are the Opportunities for the Drug Screening Market?

Disruptions in the global supply chain, diminished demand, and client suspensions have all been experienced by companies in the drug screening sector. The test examines microscopic amounts of perspiration in the fingerprint to identify drugs and drug metabolites. This test might eventually replace urine, hair, and blood-based immunoassay drug test.

Although fingerprint-based swab drug test can help prevent the spread of COVID, it is non-invasive, portable, time-saving, and sanitary, allows for social distance, is user-friendly, and requires no unique sample collection or handling preparation. 

This test is simple to administer whenever and wherever needed, making it ideal for workplace drug testing. To identify drugs and drug metabolites, at home drug test examines microscopic amounts of perspiration in the fingerprint. Workplaces, criminal justice, police enforcement, and drug recovery programs employ this test, which are offering opportunities to the market players.

Comparative View of Adjacent Drug Screening Market

Attributes

Drug Screening Market

CAGR(2022 - 2032)

16%

Market Value(2026)

US$ 11 Bn

Growth Factor

Increasing use of alcohol and drug consumption and underlying risks is increasing law enforcement.

Opportunity

Stringent regulation in North America to keep the attractive quotient of the region intact.

Key Trends

Growing drug rehabilitation centers translate to increasing adoption of drug screening devices.

 

Attributes

Drug Discovery Services Market

CAGR(2022 - 2032)

15%

Market Value(2026)

US$ 32 Bn

Growth Factor

Increasing R&D spending in biopharmaceutical and pharmaceutical industry to upkeep adoption of drug discovery services.

Opportunity

Offering skilled professionals in Asia Pacific market to provide opportunities.

Key Trends

Companies offering drug discovery services are spending towards setting up new R&D facilities.

 

Attributes

Drug Testing Market

CAGR(2022 - 2032)

5%

Market Value(2026)

US$  27.5 Bn

Growth Factor

Government mandates for monitoring and combating substance abuse to augment adoption.

Opportunity

Investment in consumables for the development of advanced products to offer lucrative opportunities.

Key Trends

Demand for innovative testing solutions for opioid to remain high.

Drug screening market future trends appear optimistic, with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories.

Fingerprint-based drug testing is a new concept that has gained traction and is one of the emerging trends in the drug screening market as a result of and impact of the COVID-19 on the drug screening market. Due to the risk of spreading the infection, the coronavirus has made it challenging to conduct drug testing in hospitals, labs, and other facilities.

Although fingerprint-based drug screening can aid in controlling COVID, it is portable, less time-consuming, and hygienic, allows for social distancing, is user-friendly, and requires no special preparation for sample collection and handling. This test is simple to implement wherever required, making it ideal for effective and flexible workplace drug testing.

The test analyses small traces of sweat in the fingerprint to detect drugs and drug metabolites. If widely used, this test is expected to replace urine, hair, and blood-based drug tests. This can be considered as one of the significant drug screening market key trends & opportunities to capitalize on and ramp up the adoption of drug screening devices etc.,

Alere, Inc. invented the xReader, a point-of-care testing device for workplace drug testing. The following year, the company created the Alere iCup Rx Drug Screen to detect commonly misused and abused prescription drugs. Furthermore, recent developments in the drug screening are expected to garner considerable revenue share and surge the sales of drug screening devices in the near future. 

Illicit drug abuse is a global social and health issue, and illicit drug monitoring use is critical in the context of public policies. It is already known that analysis of residual urban waters can yield relevant epidemiologic data. 

This drug screening method, known as wastewater-based epidemiology (WBE), is based on measuring specific markers produced by human biotransformation of the target drugs as indicators of compound consumption by the population served by the wastewater treatment installation under investigation.

Factors such as an increase in alcohol consumption among youth and the elderly population, overuse of prescribed drugs, and an increase in the use of narcotics and illicit drive the growth of the drug screening market. 

Furthermore, increased competition among manufacturers fuels the growth of the drug discovery screening market. Manufacturers are developing innovative products in broader categories to gain a larger drug screening market share.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which are the Major Drug Screening Market Segments?

The product and services for the drug screening laboratory services market are categorized into drug screening products, analytical instruments, rapid testing devices, consumables, and drug screening services. Analytical Instruments are primarily in breathalyzers, immunoassay analyzers, and chromatography instruments. Semiconductor breathalyzers have experienced increased sales in recent years as it is easy to use outdoors by law enforcement agencies. The other type of breathalyzer is the fuel cell breathalyzer.

Rapid testing devices have started gaining importance for drug monitoring programs and are predicted to overtake the global drug screening market in the coming years. This segment is further classified according to devices such as urine testing devices and oral fluid testing devices. The urine drug test devices occupy a significant share in the market in terms of volume due to the requirement of associated equipment like drug testing cups, dip cards, and drug testing cassettes.

Consumables are a recent development in the immunoassay drug test market, which is performed using assay kits, sample collection devices and calibrators & controls.

Who is the Major End User in the Drug Screening Market?

According to applications of various products and services for drug screening and development, the market caters to different end-users, namely drug testing laboratories, workplaces, criminal justice and law enforcement agencies, hospitals, drug treatment centers, pain management centers, schools and colleges, and other individual users.

Despite the development of innovative drug screening methods, drug testing laboratories and hospitals will remain the significant consumers for products of the drug screening market.

How has the Different Methods of Sample Collection Shaped the Drug Screening Market?

The sample type collected for the drug discovery screening market is classified according to urine samples, breath samples, oral fluid samples, hair samples, and other samples.

Traditionally, urine samples and breadth samples are the most used drug screening methods in different setups. Mouth swab or saliva drug tests have emerged as a widely used method after the covid-19 pandemic and promises to gain popularity in the coming years.

What is the Regional Analysis of the Drug Screening Market?

A detailed analysis of the drug screening services provided by companies across the corporates, clubs, healthcare facilities informs us about the prospect market growth across all major economies, including North America (US, Canada, and the rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Benelux, Nordic Countries and the rest of Europe), Middle East and Africa (GCC Countries, South Africa, Turkey, and rest of Middle East) and the Asia Pacific (China, Japan, South Korea and the other Pacific countries). 

According to the market survey, North America holds the largest share at 48.2% of the globe. As there has been an increase in consumption of illicit drugs by citizens of North American Countries and the government increasingly investing in curbing drug abuse by establishing drug screening laboratory services market, the region is expected to experience considerable growth in the years ahead.

The growing burden of drunk and drive cases is also becoming a significant factor in law enforcement agencies' growing demand for drug screening. Additionally, most of the primary critical players present in the North American drug screening market and adjoining areas have always favoured the colossal market volume.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Who are the Key Players in the Drug Screening Market?

The key players in the market include Labcorp, Quest Diagnostics, Abbott Laboratories, Orasure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG & CO, Lifeloc Technologies, MPD Inc., and Omega Laboratories.

Market players rely on the use of innovative technologies to derive efficiency into the drug screening kits and devices and get a hold of a better position in the drug screening market. In addition to this, the focus has also been on inorganic growth to get the benefit of collaboration and mutual growth.

Some of the other competitive players in the market for drug screening services are  Laboratory Corporation of America Holdings, Hoffmann -La Roche Ltd, BioMerieux SA, Express Diagnostics Int’l, Inc., Bio-Rad Laboratories Inc., Biomedical Diagnostics, Danaher, Synergy Health plc., Agilent Technologies, Shimadzu Medical Pvt. Ltd., Alere Inc., Premier Biotech, Inc., Psychemedics Corporation, Siemens Healthineers Private Limited, American Bio Medica Corporation, Sciteck, Inc., ACM Global Laboratories., CareHealth America, and Clinical Reference Laboratory, Inc.

Recent Developments in Drug Screening Market:

  • The Omega Hair 17-panel drug test can detect multiple psychoactive substances, particularly benzodiazepines. It was developed by Omega laboratories and was introduced in 2018.
  • Detection of any ingestion of Marijuana, CBD and nicotine drugs by a vaping panel test was introduced by Psychemedics.
  • Two US companies named Infirmary Health and LabCorp have agreed to offer laboratory testing services in the countries of the Eastern Gulf Coast. 

Another Agreement was signed between Quest Diagnostics and Select Health of South Carolina to expand their laboratory network.

Key Segments

By Sample Type:

  • Urine samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By Product and Service:

  • Drug screening
  • Analytical Instruments
  • Rapid Testing Devices
  • Consumables
  • Drug Screening Service

By End User:

  • Drug Testing Laboratories 
  • Criminal Justice and Law Enforcement Agencies 
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • Workplaces

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa

Frequently Asked Questions

The drug screening market analysis is likely to record a CAGR of 16% during 2022-2032.

The global drug screening laboratory services market was valued at US$ 5.3 Bn in 2021.

The drug screening market is set to reach US$ 18 Bn by 2032.

North America, followed by Europe, are the leading drug discovery screening markets.

Some of the key players include LabCorp, Quest Diagnostics, Abbott Laboratories, OraSure Technologies, Alfa Scientific Designs, LifeLoc, Omega Laboratories, and Premier Biotech.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Drug Screening

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Drug Screening Market, by Key Countries

    4.2. Drug Screening Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in Optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Drug Screening Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Drug Screening Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Drug Screening Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Drug Screening Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Product and Service

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product and Service, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product and Service, 2022-2032

        8.3.1. Drug Screening Product

        8.3.2. Analytical Instruments

            8.3.2.1. Breathalyzers

                8.3.2.1.1. Fuel Cell Breathalyzer

                8.3.2.1.2. Semiconductor Breathalyzer

                8.3.2.1.3. Other Breathalyzers

            8.3.2.2. Immunoassay Analyzer

            8.3.2.3. Chromatography Instruments

        8.3.3. Rapid Testing Devices

            8.3.3.1. Urine Testing Devices

                8.3.3.1.1. Drug Testing Cups

                8.3.3.1.2. Dip Cards

                8.3.3.1.3. Drug Testing Cassetts

            8.3.3.2. Oral Fluid Testing Devices

        8.3.4. Consumables

            8.3.4.1. Assay Kits

            8.3.4.2. Sample Collection Devices

            8.3.4.3. Calibrators & Controls

            8.3.4.4. Other Consumables

        8.3.5. Drug Screening Service

    8.4. Market Attractiveness Analysis By Product and Service

9. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        9.3.1. Drug Testing Laboratories

        9.3.2. Workplaces

        9.3.3. Criminal Justice and Law Enforcement Agencies

        9.3.4. Hospitals

        9.3.5. Drug Treatment Centers

        9.3.6. Individual Users

        9.3.7. Pain Management Centers

        9.3.8. Schools and Colleges

    9.4. Market Attractiveness Analysis By End User

10. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Sample Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Sample Type, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2022-2032

        10.3.1. Urine Samples

        10.3.2. Breath Samples

        10.3.3. Oral Fluid Samples

        10.3.4. Hair Samples

        10.3.5. Other Samples

    10.4. Market Attractiveness Analysis By Sample Type

11. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific 

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product and Service

        12.4.3. By Sample Type

        12.4.4. By End User

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product and Service

        12.5.3. By Sample Type

        12.5.4. By End User

13. Latin America Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product and Service

        13.4.3. By Sample Type

        13.4.4. By End User

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product and Service

        13.5.3. By Sample Type

        13.5.4. By End User

14. Europe Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product and Service

        14.4.3. By Sample Type

        14.4.4. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product and Service

        14.5.3. By Sample Type

        14.5.4. By End User

15. Asia Pacific Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product and Service

        15.4.3. By Sample Type

        15.4.4. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product and Service

        15.5.3. By Sample Type

        15.5.4. By End User

16. Middle East and Africa Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product and Service

        16.4.3. By Sample Type

        16.4.4. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product and Service

        16.5.3. By Sample Type

        16.5.4. By End User

17. Key Countries Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Drug Screening Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Product and Service

            17.2.2.2. By Sample Type

            17.2.2.3. By End User

    17.3. Canada Drug Screening Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Product and Service

            17.3.2.2. By Sample Type

            17.3.2.3. By End User

    17.4. Mexico Drug Screening Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Product and Service

            17.4.2.2. By Sample Type

            17.4.2.3. By End User

    17.5. Brazil Drug Screening Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Product and Service

            17.5.2.2. By Sample Type

            17.5.2.3. By End User

    17.6. Germany Drug Screening Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Product and Service

            17.6.2.2. By Sample Type

            17.6.2.3. By End User

    17.7. France Drug Screening Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Product and Service

            17.7.2.2. By Sample Type

            17.7.2.3. By End User

    17.8. Italy Drug Screening Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Product and Service

            17.8.2.2. By Sample Type

            17.8.2.3. By End User

    17.9. BENELUX Drug Screening Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Product and Service

            17.9.2.2. By Sample Type

            17.9.2.3. By End User

    17.10. UK Drug Screening Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Product and Service

            17.10.2.2. By Sample Type

            17.10.2.3. By End User

    17.11. Nordic Countries Drug Screening Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Product and Service

            17.11.2.2. By Sample Type

            17.11.2.3. By End User

    17.12. China Drug Screening Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Product and Service

            17.12.2.2. By Sample Type

            17.12.2.3. By End User

    17.13. Japan Drug Screening Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Product and Service

            17.13.2.2. By Sample Type

            17.13.2.3. By End User

    17.14. South Korea Drug Screening Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Product and Service

            17.14.2.2. By Sample Type

            17.14.2.3. By End User

    17.15. GCC Countries Drug Screening Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Product and Service

            17.15.2.2. By Sample Type

            17.15.2.3. By End User

    17.16. South Africa Drug Screening Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Product and Service

            17.16.2.2. By Sample Type

            17.16.2.3. By End User

    17.17. Turkey Drug Screening Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Product and Service

            17.17.2.2. By Sample Type

            17.17.2.3. By End User

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive 

        19.3.1. LABCORP

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. QUEST DIAGNOSTICS

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. ABBOTT LABORATORIES

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. ORASURE TECHNOLOGIES

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. ALFA SCIENTIFIC DESIGNS

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. THERMO FISHER SCIENTIFIC

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. DRÄGERWERK

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. LIFELOC TECHNOLOGIES

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. MPD INC.

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. OMEGA LABORATORIES

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 2: Global Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 3: Global Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 4: Global Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 5: Global Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 6: Global Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 7: Global Drug Screening Market, By Region, 2015 – 2021

Table 8: Global Drug Screening Market, By Region, 2022 – 2032

Table 9: North America Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 10: North America Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 11: North America Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 12: North America Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 13: North America Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 14: North America Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 15: North America Drug Screening Market, By Country, 2015 – 2021

Table 16: North America Drug Screening Market, By Country, 2022 – 2032

Table 17: Latin America Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 18: Latin America Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 19: Latin America Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 20: Latin America Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 21: Latin America Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 22: Latin America Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 23: Latin America Drug Screening Market, By Country, 2015 – 2021

Table 24: Latin America Drug Screening Market, By Country, 2022 – 2032

Table 25: Europe Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 26: Europe Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 27: Europe Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 28: Europe Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 29: Europe Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 30: Europe Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 31: Europe Drug Screening Market, By Country, 2015 – 2021

Table 32: Europe Drug Screening Market, By Country, 2022 – 2032

Table 33: Asia Pacific Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 34: Asia Pacific Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 35: Asia Pacific Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 36: Asia Pacific Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 37: Asia Pacific Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 38: Asia Pacific Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 39: Asia Pacific Drug Screening Market, By Country, 2015 – 2021

Table 40: Asia Pacific Drug Screening Market, By Country, 2022 – 2032

Table 41: MEA Drug Screening Market Value (US$ Mn), By Product and Service, 2015 – 2021

Table 42: MEA Drug Screening Market Value (US$ Mn), By Product and Service, 2022 – 2032

Table 43: MEA Drug Screening Market Value (US$ Mn), By Sample Type, 2015 – 2021

Table 44: MEA Drug Screening Market Value (US$ Mn), By Sample Type, 2022 – 2032

Table 45: MEA Drug Screening Market Value (US$ Mn), By End User, 2015 – 2021

Table 46: MEA Drug Screening Market Value (US$ Mn), By End User, 2022 – 2032

Table 47: MEA Drug Screening Market, By Country, 2015 – 2021

Table 48: MEA Drug Screening Market, By Country, 2022 – 2032

Table 49: Global Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 50: Global Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 51: Global Drug Screening Market Incremental $ Opportunity, By End User, 2015 - 2021

Table 52: Global Drug Screening Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 54: North America Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 55: North America Drug Screening Market Incremental $ Opportunity, By End User, 2015 – 2021

Table 56: North America Drug Screening Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 58: Latin America Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 59: Latin America Drug Screening Market Incremental $ Opportunity, By End User, 2015 - 2021

Table 60: Latin America Drug Screening Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 62: Europe Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 63: Europe Drug Screening Market Incremental $ Opportunity, By End User, 2015 - 2021

Table 64: Europe Drug Screening Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 66: Asia Pacific Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 67: Asia Pacific Drug Screening Market Incremental $ Opportunity, By End User, 2015 - 2021

Table 68: Asia Pacific Drug Screening Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Drug Screening Market Incremental $ Opportunity, By Product and Service, 2015 - 2021

Table 70: MEA Drug Screening Market Incremental $ Opportunity, By Sample Type, 2022 – 2032

Table 71: MEA Drug Screening Market Incremental $ Opportunity, By End User, 2015 - 2021

Table 72: MEA Drug Screening Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Drug Screening Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 4: Global Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 5: Global Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 6: Global Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 7: Global Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 8: Global Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 9: Global Drug Screening Market Share, By End User, 2022 & 2032

Figure 10: Global Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 11: Global Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 12: Global Drug Screening Market Share, By Region, 2022 & 2032

Figure 13: Global Drug Screening Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Drug Screening Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America Drug Screening Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 18: North America Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 19: North America Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 20: North America Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 21: North America Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 22: North America Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 23: North America Drug Screening Market Share, By End User, 2022 & 2032

Figure 24: North America Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 25: North America Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 26: North America Drug Screening Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America Drug Screening Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 32: Latin America Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 33: Latin America Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 34: Latin America Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 35: Latin America Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 36: Latin America Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 37: Latin America Drug Screening Market Share, By End User, 2022 & 2032

Figure 38: Latin America Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 39: Latin America Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 40: Latin America Drug Screening Market Share, By Country, 2022 & 2032

Figure 41: Latin America Drug Screening Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Drug Screening Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe Drug Screening Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 46: Europe Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 47: Europe Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 48: Europe Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 49: Europe Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 50: Europe Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 51: Europe Drug Screening Market Share, By End User, 2022 & 2032

Figure 52: Europe Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 53: Europe Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 54: Europe Drug Screening Market Share, By Country, 2022 & 2032

Figure 55: Europe Drug Screening Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Drug Screening Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA Drug Screening Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 60: MEA Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 61: MEA Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 62: MEA Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 63: MEA Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 64: MEA Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 65: MEA Drug Screening Market Share, By End User, 2022 & 2032

Figure 66: MEA Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 67: MEA Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 68: MEA Drug Screening Market Share, By Country, 2022 & 2032

Figure 69: MEA Drug Screening Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Drug Screening Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Drug Screening Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific Drug Screening Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Drug Screening Market Share, By Product and Service, 2022 & 2032

Figure 74: Asia Pacific Drug Screening Market Y-o-Y Growth Projections, By Product and Service – 2022-2032

Figure 75: Asia Pacific Drug Screening Market Attractiveness Index, By Product and Service – 2022-2032

Figure 76: Asia Pacific Drug Screening Market Share, By Sample Type, 2022 & 2032

Figure 77: Asia Pacific Drug Screening Market Y-o-Y Growth Projections, By Sample Type – 2022-2032

Figure 78: Asia Pacific Drug Screening Market Attractiveness Index, By Sample Type – 2022-2032

Figure 79: Asia Pacific Drug Screening Market Share, By End User, 2022 & 2032

Figure 80: Asia Pacific Drug Screening Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 81: Asia Pacific Drug Screening Market Attractiveness Index, By End User – 2022-2032

Figure 82: Asia Pacific Drug Screening Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Drug Screening Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Drug Screening Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Drug Screening Market Share, By Product and Service, 2021

Figure 87: US Drug Screening Market Share, By Sample Type, 2021

Figure 88: US Drug Screening Market Share, By End User, 2021

Figure 89: Canada Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Drug Screening Market Share, By Product and Service, 2021

Figure 91: Canada Drug Screening Market Share, By Sample Type, 2021

Figure 92: Canada Drug Screening Market Share, By End User, 2021

Figure 93: Brazil Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Drug Screening Market Share, By Product and Service, 2021

Figure 95: Brazil Drug Screening Market Share, By Sample Type, 2021

Figure 96: Brazil Drug Screening Market Share, By End User, 2021

Figure 97: Mexico Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Drug Screening Market Share, By Product and Service, 2021

Figure 99: Mexico Drug Screening Market Share, By Sample Type, 2021

Figure 100: Mexico Drug Screening Market Share, By End User, 2021

Figure 101: Germany Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Drug Screening Market Share, By Product and Service, 2021

Figure 103: Germany Drug Screening Market Share, By Sample Type, 2021

Figure 104: Germany Drug Screening Market Share, By End User, 2021

Figure 105: U.K. Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Drug Screening Market Share, By Product and Service, 2021

Figure 107: U.K. Drug Screening Market Share, By Sample Type, 2021

Figure 108: U.K. Drug Screening Market Share, By End User, 2021

Figure 109: France Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Drug Screening Market Share, By Product and Service, 2021

Figure 111: France Drug Screening Market Share, By Sample Type, 2021

Figure 112: France Drug Screening Market Share, By End User, 2021

Figure 113: Italy Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Drug Screening Market Share, By Product and Service, 2021

Figure 115: Italy Drug Screening Market Share, By Sample Type, 2021

Figure 116: Italy Drug Screening Market Share, By End User, 2021

Figure 117: BENELUX Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Drug Screening Market Share, By Product and Service, 2021

Figure 119: BENELUX Drug Screening Market Share, By Sample Type, 2021

Figure 120: BENELUX Drug Screening Market Share, By End User, 2021

Figure 121: Nordic Countries Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Drug Screening Market Share, By Product and Service, 2021

Figure 123: Nordic Countries Drug Screening Market Share, By Sample Type, 2021

Figure 124: Nordic Countries Drug Screening Market Share, By End User, 2021

Figure 125: China Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Drug Screening Market Share, By Product and Service, 2021

Figure 127: China Drug Screening Market Share, By Sample Type, 2021

Figure 128: China Drug Screening Market Share, By End User, 2021

Figure 129: Japan Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Drug Screening Market Share, By Product and Service, 2021

Figure 131: Japan Drug Screening Market Share, By Sample Type, 2021

Figure 132: Japan Drug Screening Market Share, By End User, 2021

Figure 133: South Korea Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Drug Screening Market Share, By Product and Service, 2021

Figure 135: South Korea Drug Screening Market Share, By Sample Type, 2021

Figure 136: South Korea Drug Screening Market Share, By End User, 2021

Figure 137: GCC Countries Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Drug Screening Market Share, By Product and Service, 2021

Figure 139: GCC Countries Drug Screening Market Share, By Sample Type, 2021

Figure 140: GCC Countries Drug Screening Market Share, By End User, 2021

Figure 141: South Africa Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Drug Screening Market Share, By Product and Service, 2021

Figure 143: South Africa Drug Screening Market Share, By Sample Type, 2021

Figure 144: South Africa Drug Screening Market Share, By End User, 2021

Figure 145: Turkey Drug Screening Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Drug Screening Market Share, By Product and Service, 2021

Figure 147: Turkey Drug Screening Market Share, By Sample Type, 2021

Figure 148: Turkey Drug Screening Market Share, By End User, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Drug Screening Market